Dr. Maria Monina Kane

Dr. Maria Monina Kane (DR. MARIA MONINA KANE ) is A Psychiatry & Neurology Physician in Oklahoma City, OK. The NPI Number for Dr. Maria Monina Kane is 1922050335.

The current location address for Dr. Maria Monina Kane is 1110 N CLASSEN BLVD SUITE 318 Oklahoma City, OK 73106 and the contact number is 4052325453 and fax number is 4052322295. The mailing address for Dr. Maria Monina Kane is 1110 N CLASSEN BLVD SUITE 318 Oklahoma City, OK 73106- 4052325453 (mailing address contact number - 4052325453).

A Psychiatrist specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

What is the NPI Number for Dr. Maria Monina Kane ?

Answer: The NPI Number for Dr. Maria Monina Kane is 1922050335

Where is Dr. Maria Monina Kane located?

Answer: Dr. Maria Monina Kane is located at 1110 N CLASSEN BLVD SUITE 318 Oklahoma City, OK 73106.

What is the specialty for Dr. Maria Monina Kane ?

Answer: The Specialty of Dr. Maria Monina Kane is A Psychiatry & Neurology Physician.

Are there any online reviews for Dr. Maria Monina Kane ?

Answer: Yes! Check It Now.

Are there any other health care providers in Oklahoma City, OK?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Psychiatry & Neurology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	1320
Number of Standardized 30-Day Fills	1382.2
Aggregate Cost Paid for All Claims	35974.44
Number of Day's Supply for All Claims	40288
Number of Medicare Beneficiaries	62
Number of Claims, Including Refills, for Beneficiaries Age 65+	303
Including Refills, for Beneficiaries Age 65+	357.46666667
Beneficiaries Age 65+	4993.74
Number of Day's Supply for All Claims for Beneficaries Age 65+	10364
Number of Medicare Beneficiaries Age 65+	20
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	99
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	1221
Aggregate Cost Paid for Generic Drugs	22349.12
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	732
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	17957.29
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	588
Aggregate Cost Paid for Claims Filled by	18017.15
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	1134
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	31033.64
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	186
by Low-Income Subsidy	4940.8
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	42
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	650.66
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	58.693548387
Number of Beneficiaries Age Less Than 65	42
Number of Beneficiaries Age 65 to 74	16
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	35
Number of Male Beneficiaries	27
Number of Non-Hispanic White	48
Number of Black or African American
Number of Asian Pacific Islander	0
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement	17
Average Hierarchical Condition Category	1.26388878